Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.
  • Represent a cannabis consulting company in connection with a strategic transaction
  • Represent a biotechnology company in connection with a NASDAQ listing
  • Represent a cannabis technology company in connection with a capital raising transaction
  • Represented an early private investor in a publicly-traded Canadian cannabis company
  • Represented a foreign holding company in a share purchase agreement with a company in the medical cannabis field
  • Represented a foreign holding company in a share purchase agreement with a company operation for the development of a medicine/drug in the medical cannabis field
  • Representing a private investor in a share purchase agreement in an aggregate amount of €5,000,000 with a company operating to grow and cultivate cannabis in Spain
  • Representing a private investor in negotiations for an investment in the field of medical cannabis in Macedonia
  • Representing a foreign holding company in negotiations for an investment in a company operating to extract oils from cannabis in Europe
  • Representing a Mexican company in negotiations for an investment in the amount of $80 million in the medical cannabis field
  • Represented private investors in a share purchase agreement with a company in the medical cannabis field
  • Represented private investors in a second round of investment in a company in the medical cannabis field
  • Represented a private investor in a share purchase agreement with a company in the medical cannabis field
  • Represented a private investor of MedReleaf Corp., a public company traded on the Toronto Stock Exchange, in the sale of MedReleaf Corp to Aurora Cannabis Inc.
  • Represented The Can Leaf Group in an investment for the establishment of a medical cannabis activity in a kibbutz in the south of Israel

Matters

  • Represent a cannabis consulting company in connection with a strategic transaction
  • Represent a biotechnology company in connection with a NASDAQ listing
  • Represent a cannabis technology company in connection with a capital raising transaction
  • Represented an early private investor in a publicly-traded Canadian cannabis company
  • Represented a foreign holding company in a share purchase agreement with a company in the medical cannabis field
  • Represented a foreign holding company in a share purchase agreement with a company operation for the development of a medicine/drug in the medical cannabis field
  • Representing a private investor in a share purchase agreement in an aggregate amount of €5,000,000 with a company operating to grow and cultivate cannabis in Spain
  • Representing a private investor in negotiations for an investment in the field of medical cannabis in Macedonia
  • Representing a foreign holding company in negotiations for an investment in a company operating to extract oils from cannabis in Europe
  • Representing a Mexican company in negotiations for an investment in the amount of $80 million in the medical cannabis field
  • Represented private investors in a share purchase agreement with a company in the medical cannabis field
  • Represented private investors in a second round of investment in a company in the medical cannabis field
  • Represented a private investor in a share purchase agreement with a company in the medical cannabis field
  • Represented a private investor of MedReleaf Corp., a public company traded on the Toronto Stock Exchange, in the sale of MedReleaf Corp to Aurora Cannabis Inc.
  • Represented The Can Leaf Group in an investment for the establishment of a medical cannabis activity in a kibbutz in the south of Israel